Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

Share Price is delayed by 15 minutes
Get Live Data
5,450.00    -50.00 (-0.91%)
Bid:
5,400.00
Ask:
5,450.00
Spread: 50.00 (0.926%)
Market Cap: £137.76m
CAM Live PriceLast checked at - London Stock Exchange

Intraday Camellia Share Chart

Update on BF&M Transaction

28 Jun 2024 13:00

RNS Number : 3659U
Camellia PLC
28 June 2024
 

28 June 2024

Camellia Plc

(the "Company" or the "Group")

 

Update on BF&M Transaction and change of name of Nominated Adviser

 

Update on BF&M Transaction

 

Further to the most recent update on the disposal of the Company's 36.9% shareholding in BF&M to Argus Group provided in our trading update on 6 June 2024, BF&M Limited ("BF&M") and Argus Group Holdings Limited ("Argus") announced today that the two companies plan to amalgamate (pursuant to Bermuda law), subject to receipt of appropriate shareholder and regulatory approvals (the "Amalgamation"). 

 

This announcement by BF&M and Argus establishes a way forward for regulatory approval of the sale of Camellia's holding of BF&M shares to Argus (the "Sale"). The Amalgamation is expected to take place after the completion of the Sale and special general meetings of BF&M and Argus. As previously announced, we expect the completion of the Sale will take place in the latter part of 2024.

 

To facilitate the timely completion of the Sale and the Amalgamation, Camellia and Argus have agreed that up to $50 million of the agreed $100 million consideration payable to Camellia for the BF&M shares may be deferred in the form of interest-bearing loan notes with a maximum one year term. The Sale is conditional on regulatory approvals and Argus financing. Any loan notes issued will be secured by a pledge over the shares of the buyer and a guarantee from Argus prior to the Amalgamation and, following completion of the Amalgamation, guaranteed by BF&M, the ultimate parent company of the amalgamated entity. If any of the consideration is deferred, Argus will be incentivised to pay down the loan quickly. The Company will provide further updates as appropriate.

 

Change of name of Nominated Advisor

 

The Company announces that its Nominated Adviser and Broker has changed its name to Panmure Liberum Limited following completion of its own corporate merger.

 

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

Enquiries

 

Camellia Plc 01622 746655

Byron Coombs, Chief Executive Officer

Oliver Capon, Chief Financial Officer

 

Panmure Liberum 020 7886 2500

Nominated Adviser and Broker

Emma Earl

Rupert Dearden

 

H/Advisors Maitland 

PR

William Clutterbuck 07785 292617

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEANKPAFNLEEA
Date   Source Headline
2nd Apr 20151:44 pmRNSBoard changes
24th Nov 20149:19 amRNSDirectorate Change
2nd Oct 20143:02 pmRNSDirectorate Change
19th Sep 20149:11 amRNSAdmission to AIM
19th Sep 20148:00 amRNSCancellation - Camellia PLC
9th Sep 20142:00 pmRNSUpdate on Move to AIM
2nd Sep 201410:45 amRNSHalf Yearly Report
28th Aug 20147:00 amRNSHalf Yearly Report
20th Aug 20143:15 pmRNSSch 1 - Camellia Plc
20th Aug 20142:40 pmRNSUpdate on Move to AIM
14th Aug 20143:00 pmRNSCancellation of listing on Luxembourg Exchange
6th Aug 20142:30 pmRNSResult of AGM
6th Aug 201411:27 amRNSUpdate on Move to AIM
5th Aug 201410:16 amRNSTrading Update
11th Jul 20143:11 pmRNSShareholder Circular
11th Jul 20147:00 amRNSProposed Move to AIM
13th Jun 201411:16 amRNSNotification of Major Interest In Shares
10th Jun 20142:00 pmRNSDirectorate Change
6th Jun 201411:02 amRNSResult of AGM
5th Jun 201412:30 pmRNSAGM Statement
30th Apr 20142:26 pmRNSReport and Accounts
24th Apr 20144:13 pmRNSFinal Results - Replacement
24th Apr 20147:00 amRNSFinal Results
28th Mar 20143:16 pmRNSInterim Management Statement
3rd Mar 201411:35 amRNSTotal Voting Rights
3rd Feb 201412:32 pmRNSTotal Voting Rights
20th Jan 20144:38 pmRNSTransaction in Own Shares
9th Jan 20147:00 amRNSHolding(s) in Company
9th Jan 20147:00 amRNSTransaction in Own Shares
2nd Jan 20142:42 pmRNSTotal Voting Rights
24th Dec 201311:37 amRNSTransaction in Own Shares
13th Dec 20134:15 pmRNSTransaction in Own Shares
12th Dec 20134:32 pmRNSTransaction in Own Shares
25th Nov 20134:47 pmRNSTransaction in Own Shares
21st Nov 20134:53 pmRNSTransaction in Own Shares
15th Nov 20135:12 pmRNSTransaction in Own Shares
1st Nov 20137:00 amRNSTotal Voting Rights
24th Oct 20137:00 amRNSInterim Management Statement
25th Sep 20133:46 pmRNSShare Transactions
10th Sep 20132:53 pmRNSDirector/PDMR Shareholding
4th Sep 20134:14 pmRNSTransaction in Own Shares
4th Sep 20139:48 amRNSHalf Yearly Report
29th Aug 20137:00 amRNSHalf Yearly Report
1st Jul 20139:57 amRNSTotal Voting Rights
28th Jun 20135:09 pmRNSTransaction in Own Shares
28th Jun 20134:56 pmRNSTransaction in Own Shares
24th Jun 20134:31 pmRNSTransaction in Own Shares
21st Jun 20134:43 pmRNSTransaction in Own Shares
21st Jun 20134:28 pmRNSTransaction in Own Shares
20th Jun 20134:28 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.